Álvaro Lladser, Head of the Gene Immunotherapy Lab at Fundación Ciencia & Vida, received new award from CONICYT
December 20, 2016
Dr. Álvaro Lladser, the Head of our Gene Immunotherapy Lab, has been recently awarded a FONDEF IDeA in Two Stages research grant from Conicyt to execute his project entitled “Genetic engineering of T lymphocytes with chimeric receptors for the development of immunotherapies against cancer”.
The objective behind the IDeA (Research and Development in Action) in Two Stages Grants is to support the execution of scientific and technological research projects, with potential economic and/or social impact. Approval is contingent to the project’s potential as a proof of concept or its aim at developing a model or prototype for future use.
This award is an important encouragement for Dr. Lladser’s work, which has been focused on the use of preclinical mouse models for the understanding and improvement of strategies for cancer treatment through the use of gene-based vaccines for the induction of tumor-specific T cell immunity. His current focus is on deciphering the role of resident and circulating memory cytotoxic T cells in eliminating local and disseminated metastatic tumors, respectively.
Dr. Álvaro Lladser, Head of our Gene Immunotherapy Lab, has been recently awarded a FONDEF IDeA in Two Stages research grant from Conicyt.